Cargando…
Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
Tumor necrosis factor inhibitors (TNFi) are proposed as a risk factor for nontuberculous mycobacteria (NTM) infection. Limited research investigates NTM infection risk in rheumatoid arthritis (RA) patients treated with TNFi compared to conventional synthetic disease-modifying antirheumatic drugs (cs...
Autores principales: | Park, Hyun Jin, Choi, Boyoon, Song, Yun-Kyoung, Oh, Yoon-Jeong, Lee, Eun Bong, Kim, In-Wha, Oh, Jung Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671978/ https://www.ncbi.nlm.nih.gov/pubmed/38002613 http://dx.doi.org/10.3390/jcm12226998 |
Ejemplares similares
-
The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study
por: Choi, Boyoon, et al.
Publicado: (2022) -
Correction: The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study
por: Choi, Boyoon, et al.
Publicado: (2022) -
Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea
por: Lim, Doo-Ho, et al.
Publicado: (2017) -
Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea
por: Lim, Doo-Ho, et al.
Publicado: (2021) -
Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study
por: Mori, Shunsuke, et al.
Publicado: (2020)